Patterns of Local Failure after Neoadjuvant Radiation For Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

被引：1

作者：

Rhieu, B. H. ^{[1
]}

Han-Oh, S. ^{[1
]}

Guss, Z. D. ^{[1
]}

Cheng, Z. ^{[1
]}

Meyer, J. J. ^{[1
]}

Herman, J. M. ^{[2
]}

Narang, A. ^{[1
]}

机构：

[1] Johns Hopkins Univ Hosp, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.1924

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2558

引用

页码：E243 / E243

页数：1

共 50 条

[31] The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma [J].

Lo, Victor C. K. ;

Goodwin, Rachel A. ;

Vickers, Michael M. .

JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8

[32] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer [J].

Scheufele, Florian ;

Hartmann, Daniel ;

Friess, Helmut .

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4

[33] Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer [J].

Wang, E. ;

Forsthoefel, M. K. ;

Rashid, A. ;

McGunigal, M. ;

Carrasquilla, M. ;

Unger, K. R. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03) :E659-E659

[34] Long-term outcomes with neoadjuvant chemotherapy with or without stereotactic body radiation therapy in patients with borderline resectable and locally advanced pancreatic adenocarcinoma [J].

Hill, Colin ;

Rosati, Lauren M. ;

Hu, Chen ;

Fu, Wei ;

Sehgal, Shuchi ;

Hacker-Prietz, Amy ;

He, Jin ;

Laheru, Daniel A. ;

Zheng, Lei ;

Burkhart, Richard A. ;

De Jesus-Acosta, Ana ;

Le, Dung T. ;

Hruban, Ralph H. ;

Weiss, Matthew John ;

Wolfgang, Christopher Lee ;

Narang, Amol ;

Herman, Joseph M. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)

[35] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma [J].

Kaufmann, Benedikt ;

Hartmann, Daniel ;

D'Haese, Jan G. ;

Stupakov, Pavel ;

Radenkovic, Dejan ;

Gloor, Beat ;

Friess, Helmut .

DIGESTIVE SURGERY, 2019, 36 (06) :455-461

[36] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma [J].

Shafi, S. ;

Kaubisch, A. .

PANCREAS, 2015, 44 (08) :1413-1413

[37] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma [J].

Kang, J. ;

Kim, K-P. ;

Yoo, C. ;

Lee, J-L. ;

Ryoo, B-Y. ;

Chang, H-M. ;

Lee, S. S. ;

Park, D. H. ;

Song, T. J. ;

Seo, D. W. ;

Lee, S. K. ;

Kim, M-H. ;

Hwang, D. W. ;

Song, K. B. ;

Lee, J. H. ;

Kim, S. C. .

ANNALS OF ONCOLOGY, 2016, 27

[38] Pathologic Response With Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer [J].

Rajagopalan, M. S. ;

Heron, D. E. ;

Zeh, H. J. ;

Moser, A. J. ;

Krasinskas, A. M. ;

Quinn, A. E. ;

Burton, S. A. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03) :S319-S320

[39] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma [J].

Alvarez, R. ;

Ales, I. ;

Diaz, R. ;

de Paredes, B. G. ;

Hidalgo, M. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10) :1193-1198

[40] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma [J].

R. Álvarez ;

I. Alés ;

R. Díaz ;

B. G. de Paredes ;

M. Hidalgo .

Clinical and Translational Oncology, 2017, 19 :1193-1198

← 1 2 3 4 5 →